ZVRA SCHEDULE 13G/A: SEC filing
A Schedule 13G/A amendment was
Filed with the SEC on · accession 0000315066-26-002891
ZVRA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 5, 2026. A Schedule 13G/A amendment was filed regarding Zevra Therapeutics, Inc., indicating a change in a passive institutional holder's ownership position.
Summary of the filing
A Schedule 13G/A amendment was filed regarding Zevra Therapeutics, Inc., indicating a change in a passive institutional holder's ownership position. The filing directory does not disclose specific ownership percentages or share counts.
Key details
✦ Ask GOAX AI about this filing — what it means for ZVRA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ZVRA?
Click hereFrequently asked questions
What did ZVRA file with the SEC on Nov 5, 2026?
ZVRA filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding Zevra Therapeutics, Inc., indicating a change in a passive institutional holder's ownership position. The filing directory does not disclose specific ownership percentages or share counts.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other ZVRA SEC filings
Get alerts when ZVRA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days